9/23/2011

A panel of pediatric experts voted 16-1 to recommend that the FDA continuously monitor the safety of antipsychotic treatments in children and urged the agency to make antipsychotics' labels clearer by
emphasizing their health risks to children, such as weight gain and diabetes.

Full Story:
Reuters

Related Summaries